Stromal Vascular Fraction vs Platelet Rich Plasma for Androgenetic Alopecia

This clinical trial focuses on developing effective treatments for androgenetic alopecia, commonly known as male or female pattern baldness. The study targets individuals who are experiencing hair thinning or hair loss, aiming to compare the effectiveness of two treatments: stromal vascular fraction (SVF) and platelet-rich plasma (PRP). By investigating these methods, the research seeks to provide better solutions for hair regrowth and improve overall hair density and thickness, addressing a significant concern for those suffering from this condition. Participants in the study undergo a process where their scalp is divided into two sections. One section receives an injection of SVF, which is derived from processed fat tissue, while the other section receives an injection of PRP, obtained from their own blood. The injections are given under sterile conditions with minimal discomfort, using fine needles. The effectiveness of these treatments is evaluated over a six-month period through various measures, including photographs, patient and physician assessments, and detailed hair analysis using trichoscopy. This comprehensive approach helps determine the potential benefits and improvements in hair growth and quality for the participants.